A Phase I/II Study of FG-M131 in TRBC1+ Relapsed/Refractory Peripheral T-Cell Lymphoma
Clinical trial NCT07758491 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07758491
- Sponsor
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-30
- Primary completion
- 2031-01-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.